Tatjana Mitchell - 17 Feb 2026 Form 4 Insider Report for Evolus, Inc. (EOLS)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
19 Feb 2026, 20:57:37 UTC
Prior SEC filing
09 Oct 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Jeffrey J. Plumer, as attorney-in-fact for Tatjana Mitchell

Key filing fact

Tatjana Mitchell filed Form 4 for Evolus, Inc. (EOLS) on 19 Feb 2026.

Key facts

  • This page summarizes Tatjana Mitchell's Form 4 filing for Evolus, Inc. (EOLS).
  • 3 reported transactions and 2 derivative rows are listed below.
  • Accepted by SEC: 19 Feb 2026, 20:57.

Change

  • Previous filing in this sequence was filed on 09 Oct 2025.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002089476 Primary reporting owner

Mitchell Tatjana

Relationship
Chief Financial Officer
Address
520 NEWPORT CENTER DRIVE, SUITE 1200, NEWPORT BEACH
Signature
/s/ Jeffrey J. Plumer, as attorney-in-fact for Tatjana Mitchell
Signature date
19 Feb 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

EOLS transaction

Common Stock

Award

Transaction value
$0
Shares
+121,489
Change %
+116%
Price
$0.000000
Shares after
226,092
Date
17 Feb 2026
Ownership
Direct
Footnotes
F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

EOLS transaction Derivative

Performance Restricted Stock Units

Award

Transaction value
$0
Shares
+121,489
Change %
Price
$0.000000
Shares after
121,489
Date
17 Feb 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
121,489
Exercise price
Footnotes
F2, F3
EOLS transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value
$0
Shares
+177,471
Change %
Price
$0.000000
Shares after
177,471
Date
17 Feb 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
177,471
Exercise price
$4.39
Footnotes
F4
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

Represents shares issuable upon settlement of restricted stock units (RSUs). Each RSU represents the right to receive one share of the Issuer's common stock. The RSUs vest in four equal annual installments on each anniversary of February 17, 2026, subject to continued service, and may accelerate in certain circumstances (including specified terminations or a change in control).

Footnote F2

Each performance-based restricted stock unit (PSU) represents the right to receive, following vesting, a number of shares of common stock of the issuer up to 200% of the number of PSUs.

Footnote F3

The number of shares issuable upon vesting is based on performance against pre-established financial metrics and relative total shareholder return (TSR) over a three-year performance period ending December 31, 2028. Subject to certification of performance results, any earned PSUs vest following the performance period.

Footnote F4

The shares subject to the option vest in four equal annual installments on each anniversary of February 17, 2026, subject to continued service, and may accelerate in certain circumstances (including specified terminations or a change in control).

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .